Abstract
Preview A variety of prognostic factors that offer guidelines for adjuvant systemic therapy must be confronted by breast cancer patients and their physicians. However, many questions regarding the most effective approach remain unanswered. In this article, the authors examine this complex field and review recommendations for posttreatment follow-up.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
